Medical treatment in infants and young children with epilepsy: Off‐label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children

OBJECTIVE: Antiseizure medications (ASMs) remain the mainstay of epilepsy treatment. These ASMs have mainly been tested in trials in adults with epilepsy, which subsequently led to market authorization (MA). For treatment of – especially young – children with epilepsy, several ASMs do not have a MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sourbron, Jo, Auvin, Stéphane, Arzimanoglou, Alexis, Cross, J. Helen, Hartmann, Hans, Pressler, Ronit, Riney, Kate, Sugai, Kenji, Wilmshurst, Jo M., Yozawitz, Elissa, Lagae, Lieven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977757/
https://www.ncbi.nlm.nih.gov/pubmed/36281833
http://dx.doi.org/10.1002/epi4.12666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977757/
https://www.ncbi.nlm.nih.gov/pubmed/36281833
http://dx.doi.org/10.1002/epi4.12666

Ejemplares similares